PMC Links for Books (Select 4861914) - PMC

Select item 56612801.

Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease

Vladimir Tesar, Kazimierz Ciechanowski, York Pei, Irina Barash, Megan Shannon, Ray Li, Jason H. Williams, Matteo Levisetti, Steven Arkin, Andreas Serra

J Am Soc Nephrol. 2017 Nov; 28(11): 3404–3413. Published online 2017 Aug 24. doi: 10.1681/ASN.2016111232

PMCID:: PMC5661280

Abstract Article

Select item 49166182.

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Jorge E. Cortes, Hagop M. Kantarjian, Tim H. Brümmendorf, Dong-Wook Kim, Anna G. Turkina, Zhi-Xiang Shen, Ricardo Pasquini, H. Jean Khoury, Steven Arkin, Angela Volkert, Nadine Besson, Richat Abbas, Junyuan Wang, Eric Leip, Carlo Gambacorti-Passerini

Blood. 2011 Oct 27; 118(17): 4567–4576. Prepublished online 2011 Aug 24. doi: 10.1182/blood-2011-05-355594

Correction in:: Blood. 2013 Oct 3; 122(14): 2524.

PMCID:: PMC4916618

Abstract Article

Select item 44462353.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 43052124.

Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia

Carlo Gambacorti-Passerini, Jorge E Cortes, Jeff H Lipton, Anna Dmoszynska, Raymond S Wong, Victor Rossiev, Dmitri Pavlov, Karin Gogat Marchant, Ladan Duvillié, Navin Khattry, Hagop M Kantarjian, Tim H Brümmendorf

Am J Hematol. 2014 Oct; 89(10): 947–953. Published online 2014 Jul 21. doi: 10.1002/ajh.23788

PMCID:: PMC4305212

Abstract Article PDF–417K

Select item 42749785.

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial

Tim H Brümmendorf, Jorge E Cortes, Cármino Antonio de Souza, Francois Guilhot, Ladan Duvillié, Dmitri Pavlov, Karïn Gogat, Athena M Countouriotis, Carlo Gambacorti-Passerini

Br J Haematol. 2015 Jan; 168(1): 69–81. Published online 2014 Sep 8. doi: 10.1111/bjh.13108

PMCID:: PMC4274978

Abstract Article PDF–333K

Select item 41731276.

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

Carlo Gambacorti-Passerini, Tim H Brümmendorf, Dong-Wook Kim, Anna G Turkina, Tamas Masszi, Sarit Assouline, Simon Durrant, Hagop M Kantarjian, H Jean Khoury, Andrey Zaritskey, Zhi-Xiang Shen, Jie Jin, Edo Vellenga, Ricardo Pasquini, Vikram Mathews, Francisco Cervantes, Nadine Besson, Kathleen Turnbull, Eric Leip, Virginia Kelly, Jorge E Cortes

Am J Hematol. 2014 Jul; 89(7): 732–742. Published online 2014 Apr 8. doi: 10.1002/ajh.23728

PMCID:: PMC4173127

Abstract Article PDF–910K

Select item 39838157.

The European Medicines Agency Review of Bosutinib for the Treatment of Adult Patients With Chronic Myelogenous Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Zahra Hanaizi, Christoph Unkrig, Harald Enzmann, Jorge Camarero, Arantxa Sancho-Lopez, Tomas Salmonson, Christian Gisselbrecht, Edward Laane, Francesco Pignatti

Oncologist. 2014 Apr; 19(4): 421–425. Published online 2014 Mar 25. doi: 10.1634/theoncologist.2013-0294

PMCID:: PMC3983815

Abstract Article PDF–880K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 7

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity